Most common Multiple sclerosis (MS) medications include steroids, interferons, and various immune-modulating drugs.
These medications work by suppressing the immune response to reduce inflammation and nerve damage.
In this article, we will look into some effective MS medications, their uses, MOA, and side effects.
You may also like to read: |
What is Multiple Sclerosis?
Multiple sclerosis (MS) is a chronic demyelinating disease of the central nervous system. A variety of drugs are available to manage its symptoms and slow the progression of the disease. However, until now, there is no drug to cure it.
Commonly used MS Medications include steroids and disease-modifying drugs.
According to studies, the treatment of MS falls into the following categories:
- Treatment of aggravations
- Slowing progress with Disease-modifying drugs
- Symptomatic therapy
You may also like to read: |
Treatment Options for MS
Here is a list of medications that can be used in the treatment of Multipla sclerosis (MS):
Steroids
These include oral prednisolone or IV methylprednisolones, which are used to treat acute relapses of MS.
They reduce the duration of relapse but do not guarantee that the patient will return to their baseline functionality.
Side effects of steroids include infections, osteoporosis, proximal myopathy, impaired glucose tolerance, and a deranged lipid profile.
Disease-modifying drugs:
A class of drugs that are immunomodulators and help slow the frequency and duration of relapse by preventing antibodies from forming against the myelin sheath. Some examples of disease-modifying drugs are:
Interferons
These include interferon beta 1-a, interferon beta 1-b, and peg-interferon beta 1a which are commonly used in MS.
They are used to alleviate the frequency and duration of acute relapses and have particular indications for which they can be used.
Side effects of interferons include flu-like illness, myalgias, fever, hair loss, dizziness, gingivitis, peripheral neuropathy, and visual abnormalities.
Glatiramer acetate
It is used to reduce the frequency of relapses and lesions in the brain. Glatiramer acetate binds to the MHC molecules and consequently competes with various myelin antigens for their presentation to T cells.
Side effects of glatiramer acetate include anxiety, bleeding from the mucosa, chest tightness, cough, palpitations, and low-grade fever with chills.
Cladribine
Cladribine is used in patients who have not responded to or who were unable to tolerate other potent MS Medications.
It is present in oral formulation taken once a day for 5 days for one month then once a day for the second month.
Cladribine-phosphates act by interfering with DNA synthesis and repair through incorporation into DNA and through inhibition of enzymes involved in DNA metabolism.
Side effects of cladribine include flu-like illness, chest tightness, skin rash, headaches, swelling of eyelids, face, and tongue, and arthralgias.
Diroximel fumarate
Diroximel fumarate is indicated for the treatment of relapsing forms of MS in adults. It is considered safer than dimethyl fumarate.
It is said to regulate cell signaling pathways and has neuroprotective effects as a result of its immune-modulatory effects.
Side effects of Diroximel fumarate include leucopenia, progressive multifocal leukoencephalopathy, opportunistic infections, and skin allergic reactions.
Fingolimod
It is used to reduce relapse rates and delay disease progression. It works by trapping lymphocytes in the lymph nodes thereby reducing the number of lymphocytes in the blood and the brain.
Side effects of fingolimod include bradycardia, macular edema, infections, hypertension, and hepatic impairment.
You may also like to read: |
Summary of MS medications:
Drug | Indications | Mechanism of action | Pregnancy | Lactation | Side effects |
Steroids | Acute exacerbations | Immunosuppression via decreasing the production of antibodies. | Safe | Safe |
|
Interferons | Reduce the frequency and duration of acute exacerbations | Interferes with viral replication, modulates the immune response | Avoid | Avoid |
|
Glatiramer acetate | Relapsing-remitting MS | Modulates immune response | Use with caution | Use with caution |
|
Dimethyl fumarate | Relapsing-remitting MS | May modulate the immune response | Avoid | Use with caution |
|
Fingolimod | Relapsing forms of MS | Sphingosine 1-phosphate receptor modulator | Avoid | Avoid |
|
Natalizumab | Highly active relapsing-remitting MS | Targets α4-integrin and prevents migration of immune cells into CNS | Avoid | Use with caution |
|
Alemtuzumab | Relapsing-remitting MS | Depletes CD52+ lymphocytes | Avoid | Use with caution |
|
Ocrelizumab | Relapsing-remitting MS, primary progressive MS | Depletes CD20+ B cells | Use with caution | Use with caution |
|
Cladribine | Relapsing-remitting MS | Induces lymphocyte apoptosis | Avoid | Use with caution |
|
These medications have different mechanisms of action and may be prescribed individually based on the type and severity of MS in patients, as well as the individual patient’s medical history and preferences.
It is important to work closely with a healthcare provider to determine the best treatment plan for MS.
You may also like to read: |